Research Reveals a Fundamental Shift in How Investors View ESG
As recently as five years ago, environmental, social, and governance (ESG) investing was pitched as a market revolution—led by idealistic young investors and destined to reinvent investing. Five years and a few economic shocks later, the revolution looks more like a recalibration—but that doesn’t mean ESG has disappeared. Our research finds that enthusiasm hasn’t vanished;
» Read more about: Research Reveals a Fundamental Shift in How Investors View ESG »
Read MorePros and Cons of a Fixed-Rate Mortgage
Buying a home is likely to be the largest purchase you will make during your lifetime. It’s important that you understand the terms of your loan and work with your lender to identify the best loan product for your situation. When looking at loan options, understand the advantages and disadvantages of a fixed-rate mortgage (FRM) and how it compares to an adjustable-rate mortgage.
» Read more about: Pros and Cons of a Fixed-Rate Mortgage »
Read MoreRivian Stock: The EV Recovery Play to Watch
Key Points
-
Rivian shares soared by more than 25% after its most recent quarterly earnings report.
-
The company is forecasting up to a 59% increase in vehicle deliveries in 2026.
-
The electric vehicle maker’s first mass-market SUV, the Rivian R2,
» Read more about: Rivian Stock: The EV Recovery Play to Watch »
Read MoreJacob Funds’ Q4 2025 Investor Letter
When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.
Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.
» Read more about: Jacob Funds’ Q4 2025 Investor Letter »
Read MoreEnergy Transfer's Units Surged Nearly 12% in January
Key Points
-
The energy sector got off to an encouraging start in January.
-
Energy Transfer has a more stable business than upstream companies.
-
The limited partnership’s units have an attractive yield right now.
The S&P 500 got off to a decent start during the first month of the year,
» Read more about: Energy Transfer's Units Surged Nearly 12% in January »
Read MoreThe Burst
1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services,
» Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read MoreThe Ivy
The Danger Is Still High, Here’s Why
After a face-ripping rally Wednesday, markets took a breather yesterday. Futures were pointing lower, which, frankly, wasn’t all that surprising given how sharply things ripped higher.
But while some have pointed to a bottom, the reality is the danger is still high. Look no further than how the rally failed at the downtrending resistance line.
» Read more about: The Danger Is Still High, Here’s Why »
Read MoreThe Spotlight
Spotlight: 1 High-paying Dividend Stock Is Way Undervalued
Wall Street analysts seem pretty gung-ho about Realty Income, pegging an average price target at $68 per share, a significant pop from where the stock sits now. That’s in addition to a dividend yield north of 6%.
Is Wall Street right or is the recent selloff indicative of what’s to come for Realty Income?
» Read more about: Spotlight: 1 High-paying Dividend Stock Is Way Undervalued »